Ontology highlight
ABSTRACT: Background
Breast cancer subtypes are known to have different metastatic recurrence sites. Distant metastases are often observed during the post-operative course in patients with human epidermal growth factor receptor 2 (HER2)-enriched breast cancer and triple-negative breast cancer, but are relatively rare in those with hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer. Tumor-infiltrating lymphocytes (TILs) serve as an index to monitor tumor immune microenvironment and may possibly predict the prognosis and therapeutic effect in breast cancer. This study aimed to investigate the correlation between TIL density and recurrence site in HR+/HER2- breast cancer.Methods
In stages I-II of HR+/HER2- breast cancer patients who underwent surgery as the first trea
SUBMITTER: Takada K
PROVIDER: S-EPMC8164786 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature